← All companies

MD

Pediatrix Medical Group, Inc.

MD NYSE Services-Hospitals EDGAR ↗

$26.25

-0.26 -0.98%

Key statistics

from XBRL data in SEC filings

Market cap

$2.13B

Revenue (TTM)

$1.95B

Net income (TTM)

$175M

EPS (TTM)

$2.09

P/E ratio

12.6

Dividend yield

—

Free cash flow

—

Cash

$289M

Total assets

$2.13B

Gross margin

—

52-week range

$12.77 – $27.94

Recent SEC filings

40 most recent

Annual, quarterly & current reports

10-Q Quarter ended 2026-06-30 Aug 4, 2026 8-K Results of operations (earnings release) Aug 4, 2026 8-K Director or officer change; Regulation FD disclosure Jul 24, 2026 8-K Results of operations (earnings release); Regulation FD disclosure Jul 15, 2026 8-K Director or officer change; Shareholder vote results May 7, 2026 10-Q Quarter ended 2026-03-31 May 5, 2026 8-K Results of operations (earnings release) May 5, 2026 10-K Fiscal year ended 2025-12-31 Feb 19, 2026 8-K Results of operations (earnings release) Feb 19, 2026 10-Q Quarter ended 2025-09-30 Nov 3, 2025 8-K Results of operations (earnings release) Nov 3, 2025 8-K Regulation FD disclosure; Other events Aug 18, 2025 10-Q Quarter ended 2025-06-30 Aug 5, 2025 8-K Results of operations (earnings release) Aug 5, 2025 8-K Director or officer change; Regulation FD disclosure Jul 1, 2025 8-K Shareholder vote results May 8, 2025 10-Q Quarter ended 2025-03-31 May 6, 2025 8-K Results of operations (earnings release) May 6, 2025 8-K Entered a material agreement Apr 18, 2025 10-K Fiscal year ended 2024-12-31 Feb 20, 2025 8-K Results of operations (earnings release) Feb 20, 2025 8-K Director or officer change Jan 14, 2025 8-K Results of operations (earnings release); Regulation FD disclosure Jan 13, 2025 8-K Director or officer change Dec 5, 2024 10-Q Quarter ended 2024-09-30 Nov 1, 2024 8-K Results of operations (earnings release) Nov 1, 2024 10-Q Quarter ended 2024-06-30 Aug 6, 2024 8-K Results of operations (earnings release); Director or officer change Aug 6, 2024 8-K Director or officer change Jun 17, 2024 8-K Regulation FD disclosure May 30, 2024 8-K Shareholder vote results May 9, 2024 10-Q Quarter ended 2024-03-31 May 7, 2024 8-K Results of operations (earnings release) May 7, 2024 8-K Entered a material agreement Apr 25, 2024 10-K Fiscal year ended 2023-12-31 Feb 20, 2024 8-K Results of operations (earnings release) Feb 20, 2024 10-Q Quarter ended 2023-09-30 Nov 2, 2023 8-K Results of operations (earnings release) Nov 2, 2023 10-Q Quarter ended 2023-06-30 Aug 3, 2023 8-K Results of operations (earnings release) Aug 3, 2023